Safety and Efficacy of Argatroban in the Management of Heparin-Induced Thrombocytopenia
Heparin-induced thrombocytopenia (HIT) is a life-threatening adverse reaction to heparin therapy that is characterized by thrombocytopenia and an increased risk of venous and arterial thrombosis. According to guidelines, in patients with strongly suspected or confirmed HIT all sources of heparin hav...
Main Authors: | Bernd Saugel, Roland M. Schmid, Wolfgang Huber |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-01-01
|
Series: | Clinical Medicine Insights: Blood Disorders |
Online Access: | https://doi.org/10.4137/CMBD.S5118 |
Similar Items
-
Safety and Efficacy of Argatroban in the Management of Heparin-Induced Thrombocytopenia
by: Bernd Saugel, et al.
Published: (2011-07-01) -
Argatroban in the management of heparin-induced thrombocytopenia
by: Luciano Babuin, et al.
Published: (2010-09-01) -
Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
by: Haytham Hasan, et al.
Published: (2023-01-01) -
Heparin-induced thrombocytopenia
by: Shaikh Nissar
Published: (2011-01-01) -
Heparin-induced thrombocytopenia
by: Prakash Shastri, et al.
Published: (2021-01-01)